Chronic subdural hematoma (CSDH) is a common neurological disease with an increasing incidence among the elderly.
We are interested in the effect of different types of treatment on several outcomes. All outcomes are measured at 3 months after diagnosis.
- Functional outcome, expressed by the modified Rankin Scale (mRS)
A multicenter, prospective cohort study.